CLEVELAND, Ohio — Families can now test for flu, COVID-19 and respiratory syncytial virus with one at-home test. The ...
Used with the cobas ® 5800, 6800 and 8800 systems, cobas Respiratory 4-flex simultaneously detects and differentiates the four most common respiratory viruses, helping to ensure confidence in ...
New TAGS (Temperature-Activated Generation of Signal) technology enables up to 15 targets to be detected simultaneously in a single patient sample on the high throughput molecular diagnostic analysers ...
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Roche launched the first test using the company’s ...
Highly multiplexed test offers workflow advantages to support the Flu season surge SYDNEY--(BUSINESS WIRE)--SpeeDx Pty. Ltd. today announced the clearance of the PlexPCR® RespiVirus * test from the ...
(RTTNews) - Roche (RHHBY) said it has launched three molecular PCR diagnostic test panels to simultaneously detect and differentiate common respiratory pathogens. They are influenza A, influenza B and ...
The US Food and Drug Administration (FDA) has granted 510(k) clearance and a Clinical Laboratory Improvement Amendments (CLIA) waiver for Visby Medical’s polymerase chain reaction (PCR) test to detect ...
SYDNEY--(BUSINESS WIRE)--SpeeDx Pty. Ltd. today announced submission of their PlexPCR® RespiVirus test to the Therapeutic Goods Administration (TGA). The company anticipates clearance in time for the ...
Roche announced the launch of the cobas Respiratory flex test, the first to use Roche’s novel and proprietary TAGS (Temperature-Activated Generation of Signal) technology. TAGS technology, developed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results